1-7 of 7
Barry Hancock
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Involved Field Radiotherapy Versus No Further Treatment in Patients with Clinical Stages IA and IIA Hodgkin Lymphoma and a ‘Negative’ PET Scan After 3 Cycles ABVD. Results of the UK NCRI RAPID Trial

John Radford, Sally Barrington, Nicholas Counsell, Ruth Pettengell, Peter Johnson, Jennie Wimperis, Stewart Coltart, Dominic Culligan, Andrew Lister, Eric Bessell, Anton Kruger, Bilyana Popova, Barry Hancock, Peter Hoskin, Timothy Illidge, Michael O'Doherty
Journal: Blood
Blood (2012) 120 (21): 547.
https://doi.org/10.1182/blood.V120.21.547.547
Published: 2012
Journal Articles

Quality Control of PET Imaging in a Multicentre Phase III Trial (RAPID) Involving Randomisation of Patients with Stages IA and IIA Hodgkin Lymphoma Who Are PET ‘negative’ after 3 Cycles of ABVD Chemotherapy.

Sally F Barrington, Michael J O’Doherty, Jane MacKewn, Paul Schleyer, Wendi Qian, Philippa Patrick, Timothy Illidge, Ruth Pettengell, Peter Hoskin, Barry Hancock, John Radford
Journal: Blood
Blood (2008) 112 (11): 1449.
https://doi.org/10.1182/blood.V112.11.1449.1449
Published: 2008
Journal Articles

Randomised Comparison of the Stanford V (SV) Regimen and ABVD in the Treatment of Advanced Hodgkin Lymphoma (HL): Results from a UK NCRI Lymphoma Group Study, ISRCTN 64141244

Peter W.M. Johnson, MD, FRCP, Alan Horwich, PhD, FRCR, MRCP, Andrew Jack, MD, FRCPath, Graham Mead, DM, FRCP, Barry Hancock, MD, FRCP, Paul Smith, Wendi Qian, Philippa Patrick, PhD, Andrew Pettitt, David Cunningham, Peter Hoskin, MD, FRCR
Journal: Blood
Blood (2008) 112 (11): 370.
https://doi.org/10.1182/blood.V112.11.370.370
Published: 2008
Journal Articles

Consolidation Radiotherapy Is Associated with Improved Outcomes after Chemotherapy for Advanced Hodgkin Lymphoma: Analysis of Results from the UKLG LY09 Trial (ISRCTN97144519)

Peter W.M. Johnson, MD, FRCP, Matthew R Sydes, John Radford, MD, FRCP, Michael Cullen, MD, FRCP, Sally Stenning, Barry Hancock, MD, FRCP
Journal: Blood
Blood (2008) 112 (11): 368.
https://doi.org/10.1182/blood.V112.11.368.368
Published: 2008
Journal Articles

Results of the 2nd Planned Interim Analysis of the RAPID Trial (involved field radiotherapy versus no further treatment) in Patients with Clinical Stages 1A and 2A Hodgkin Lymphoma and a ‘negative’ FDG-PET Scan after 3 Cycles ABVD

John Radford, Michael O’Doherty, Sally Barrington, Wendi Qian, Philippa Patrick, Stewart Coltart, Dominic Culligan, Jennie Wimperis, Eric Bessell, David Linch, Peter Johnson, David Cunningham, T. Andrew Lister, Peter Hoskin, Ruth Pettengell, Barry Hancock, Timothy Illidge
Journal: Blood
Blood (2008) 112 (11): 369.
https://doi.org/10.1182/blood.V112.11.369.369
Published: 2008
Journal Articles

Stanford V (SV) Regimen Versus ABVD for the Treatment of Advanced Hodgkin Lymphoma (HL): Results of a UK NCRI/LTO Randomised Phase II Trial.

Peter Johnson, MD, Peter Hoskin, MD, Alan Horwich, MD, Barry Hancock, MD, Paul Smith, Lindsey Stevens, Wendy Qian, John William Sweetenham, MD
Journal: Blood
Blood (2004) 104 (11): 311.
https://doi.org/10.1182/blood.V104.11.311.311
Published: 2004
Journal Articles

Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO

Clinical Trials & Observations
Paul N. Mainwaring, David Cunningham, Walter Gregory, Peter Hoskin, Barry Hancock, Andrew J. Norton, Ken MacLennan, Paul Smith, Gillian Vaughan Hudson, David Linch
Journal: Blood
Blood (2001) 97 (10): 2991–2997.
https://doi.org/10.1182/blood.V97.10.2991
Published: 2001